Recently Updated
- 12/15/2009
- Medical Abortion Guidebook
- 11/05/2009
- List of Mifepristone Approval
- 11/04/2009
- Map of Mifepristone Approval
- 05/25/2009
- Clinical Studies List
- 05/04/2009
- Medical Abortion Program Brief
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Methotrexate compared to misoprostol alone for early medical abortion
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Are two doses of misoprostol after mifepristone for early abortion better than one?
Mifepristone for late first trimester abortion
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Misoprostol for incomplete abortion in Mozambique
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Integrating medical abortion into safe abortion services in South Africa
Misoprostol for incomplete abortion in Burkina Faso
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Misoprostol: A New Addition to Post Abortion Care
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
The supreme court and the partial-birth abortion ban act of 2003
Sublingual misoprostol for incomplete abortion
Alternatives to mifepristone for early medical abortion
Are two doses of misoprostol after mifepristone for early abortion better than one?
Mifepristone for late first trimester abortion
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Route of Misoprostol Administration
Abortion and sex determination
Mifepristone medical abortion in Albania
Sublingual misoprostol after mifepristone
Acceptability and feasibility of medical abortion in Nepal
Home administration of misoprostol for early medical abortion in India
Alternatives to Routine Follow-Up for Early Medical Abortion
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Misoprostol for incomplete abortion in Mozambique
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Use of sequential serum hCG and sonography for medical abortion only when indicated
Can mifepristone medical abortion be simplified?
Misoprostol for incomplete abortion in Tanzania
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Alternatives to Routine Follow-Up for Early Medical Abortion
Sublingual misoprostol after mifepristone
Sublingual misoprostol for incomplete abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Integrating medical abortion into safe abortion services in South Africa
Are two doses of misoprostol after mifepristone for early abortion better than one?
Mifepristone for late first trimester abortion
Two distinct oral routes of misoprostol in mifepristone medical abortion
Two distinct oral routes of misoprostol in mifepristone medical abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Integrating medical abortion into safe abortion services in South Africa
Abortion in the Middle East and North Africa
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Misoprostol for incomplete abortion in Burkina Faso
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Misoprostol for incomplete abortion in Mozambique
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Integrating medical abortion into safe abortion services in South Africa
Sublingual misoprostol after mifepristone
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Sublingual misoprostol for incomplete abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Regimens of misoprostol with mifepristone for early medical abortion
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Two distinct oral routes of misoprostol in mifepristone medical abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
PPH Misoprostol Adjunct Treatment Study
Misoprostol PPH Treatment Study
Postpartum Hemorrhage: Responding to the Challenge
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Blood Loss After Vaginal Delivery
Fever after treatment of postpartum hemorrhage
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Home administration of misoprostol for early medical abortion in India
Sublingual misoprostol after mifepristone
Misoprostol to treat missed abortion in the first trimester
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Mifepristone medical abortion in Albania
Use of sequential serum hCG and sonography for medical abortion only when indicated
Can mifepristone medical abortion be simplified?
Two distinct oral routes of misoprostol in mifepristone medical abortion
Two distinct oral routes of misoprostol in mifepristone medical abortion
Can mifepristone medical abortion be simplified?
Regimens of misoprostol with mifepristone for early medical abortion
Route of Misoprostol Administration
FAQs on Fatal Infection and Medical Abortion - Summary
FAQs on Fatal Infection and Medical Abortion - Technical Version
Outlook Newsletter on Hormonal Contraception and HIV
Issue Brief on Hormonal Contraception and HIV
FAQ on Hormonal Contraception and HIV
Relationship of Hormonal Contraception to HIV
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Misoprostol: A New Addition to Post Abortion Care
PPH Misoprostol Adjunct Treatment Study
Misoprostol PPH Treatment Study
Postpartum Hemorrhage: Responding to the Challenge
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Misoprostol for Prevention of Postpartum Hemorrhage
Misoprostol and Teratogenicity: Reviewing the Evidence
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Annotated Bibliography - Misoprostol for Early Abortion
Misoprostol for Early Abortion
PPH Prevention Study in Pakistan
Training and Education Activities Brief
PPH Treatment Study in Pakistan
Misoprostol for Incomplete Abortion and Miscarriage
Medical Abortion Program Brief
Postpartum Hemorrhage Program Brief
Pregnancy Failure and Miscarriage Program Brief
Materials Development Activities Brief
Policy and Advocacy Activities Brief
Social Science Research Activities Brief
Technical Assistance Activities Brief
STIs/ HIV/ Infectious Disease Program Brief
Reference List - Misoprostol for Early Abortion
Blood Loss After Vaginal Delivery
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Fever after treatment of postpartum hemorrhage
Expanding Choice in Abortion Services in Armenia
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Abortion in the Middle East and North Africa
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Annotated Bibliography - Mifepristone Medical Abortion
Home administration of misoprostol for early medical abortion in India
Use of sequential serum hCG and sonography for medical abortion only when indicated
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Integrating medical abortion into safe abortion services in South Africa
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Two distinct oral routes of misoprostol in mifepristone medical abortion
Issue Brief on Hormonal Contraception and HIV
Regimens of misoprostol with mifepristone for early medical abortion
Misoprostol for incomplete abortion in Tanzania
Alternatives to mifepristone for early medical abortion
Acceptability and feasibility of medical abortion in Nepal
Mifepristone medical abortion in Albania
Integrating medical abortion into safe abortion services in South Africa
Misoprostol for incomplete abortion in Tanzania
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Are two doses of misoprostol after mifepristone for early abortion better than one?
Acceptability and feasibility of medical abortion in Nepal
Misoprostol for incomplete abortion in Burkina Faso
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Alternatives to Routine Follow-Up for Early Medical Abortion
Acceptability and feasibility of medical abortion in Nepal
Are two doses of misoprostol after mifepristone for early abortion better than one?
Mifepristone medical abortion in Albania
Misoprostol for incomplete abortion in Tanzania
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Mifepristone medical abortion in Albania
Alternatives to mifepristone for early medical abortion
Two distinct oral routes of misoprostol in mifepristone medical abortion
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Mifepristone for late first trimester abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Abortion and sex determination
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Misoprostol for incomplete abortion in Burkina Faso
Use of sequential serum hCG and sonography for medical abortion only when indicated
Outlook Newsletter on Hormonal Contraception and HIV
Misoprostol and Teratogenicity: Reviewing the Evidence
Acceptability and feasibility of medical abortion in Nepal
Misoprostol for Women's Health
Misoprostol and Teratogenicity: Reviewing the Evidence
Abortion in the Middle East and North Africa
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Two distinct oral routes of misoprostol in mifepristone medical abortion
Misoprostol for incomplete abortion in Burkina Faso
Sublingual misoprostol after mifepristone
Sublingual misoprostol for incomplete abortion
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Sublingual misoprostol for incomplete abortion
Are two doses of misoprostol after mifepristone for early abortion better than one?
FAQs on Fatal Infection and Medical Abortion - Summary
Issue Brief on Hormonal Contraception and HIV
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Misoprostol for Early Abortion
Misoprostol for Incomplete Abortion and Miscarriage
Abortion in the Middle East and North Africa
Mifepristone for late first trimester abortion
Treatment of incomplete abortion and miscarriage with misoprostol
Alternatives to Routine Follow-Up for Early Medical Abortion
Misoprostol for Women's Health
Misoprostol and Teratogenicity: Reviewing the Evidence
Supervision for use of mifepristone medical abortion
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Two distinct oral routes of misoprostol in mifepristone medical abortion
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Regimens of misoprostol with mifepristone for early medical abortion
Mifepristone medical abortion in Albania
Regimens of misoprostol with mifepristone for early medical abortion
Misoprostol for incomplete abortion in Tanzania
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Non-physician clinicians can safely provide first trimester medical abortion
Comparison of serum markers for thrombophilia and autoimmune disease
Alternatives to Routine Follow-Up for Early Medical Abortion
Mifepristone medical abortion in Albania
Mifepristone medical abortion in Albania
Misoprostol for incomplete abortion in Burkina Faso
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Sublingual misoprostol after mifepristone
Misoprostol for incomplete abortion in Mozambique
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Home administration of misoprostol for early medical abortion in India
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Integrating medical abortion into safe abortion services in South Africa
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Mifepristone for late first trimester abortion
Misoprostol for incomplete abortion in Mozambique
Misoprostol for incomplete abortion in Tanzania
Misoprostol: A New Addition to Post Abortion Care
Comparison of serum markers for thrombophilia and autoimmune disease
Alternatives to mifepristone for early medical abortion
Regimens of misoprostol with mifepristone for early medical abortion
Are two doses of misoprostol after mifepristone for early abortion better than one?
Can mifepristone medical abortion be simplified?
Mifepristone for late first trimester abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Methotrexate compared to misoprostol alone for early medical abortion
The supreme court and the partial-birth abortion ban act of 2003
Misoprostol for incomplete abortion in Mozambique
Misoprostol for incomplete abortion in Burkina Faso
Misoprostol for incomplete abortion in Tanzania
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Misoprostol for Women's Health
Supervision for use of mifepristone medical abortion
Alternatives to mifepristone for early medical abortion
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Two distinct oral routes of misoprostol in mifepristone medical abortion
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Integrating medical abortion into safe abortion services in South Africa
Clostridium sordellii infection in medical abortion
Regimens of misoprostol with mifepristone for early medical abortion
Mifepristone medical abortion in Albania
Misoprostol and Teratogenicity: Reviewing the Evidence
Sublingual misoprostol after mifepristone
Sublingual misoprostol for incomplete abortion
Increasing women's choices in medical abortion in Turkey
Non-physician clinicians can safely provide first trimester medical abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Alternatives to Routine Follow-Up for Early Medical Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Alternatives to mifepristone for early medical abortion
Non-physician clinicians can safely provide first trimester medical abortion
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Perspectives on reproductive decision-making amongst HIV-infected individuals